<?xml version="1.0" encoding="utf-8"?>
<iati-activities version="2.03" generated-datetime="2026-11-07T11:38:29+00:00">
  <iati-activity last-updated-datetime="2026-11-07T09:53:07+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-BFA-C-FDC-1</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Scaling-up high impact and integrated community interventions in the fight against HIV/AIDS and tuberculosis - Burkina Faso (01-Jan-2025-31-Dec-2026)</narrative>
    </title>
    <description type="1">
      <narrative>Burkina Faso, TB/HIV, Faso - Action pour le Développement Communautaire</narrative>
    </description>
    <description type="2">
      <narrative>Goals: Améliorer l’état de santé de la population // Improve the health status of the population; Contribuer à l'amélioration de l'état de santé de la population en réduisant le fardeau du paludisme d'ici 2026 // Contribute to improving the health status of the population by reducing the burden of malaria by 2026; Contribuer à l’amélioration de l’état de santé de la population du Burkina Faso en réduisant le poids de la tuberculose d’ici à fin 2026. // Contribute to improving the health status of the population of Burkina Faso by reducing the burden of tuberculosis by the end of 2026; Contribuer à l’amélioration de l’état de santé de la population du Burkina Faso en réduisant le poids du VIH d’ici à fin 2026. // Contribute to improving the health status of the population of Burkina Faso by reducing the burden of HIV by the end of 2026. Objectives: Augmenter l’utilisation des services de santé pour réduire les mortalités et morbidités dues aux maladies transmissibles et non transmissibles // Increase the use of health services to reduce mortality and morbidity due to communicable and non-communicable diseases; Rendre disponible les infrastructures sanitaires, les équipements et les produits de santé, selon les normes et les besoins, dans 95% des formations sanitaires. // Make health infrastructures, equipment and products available, according to standards and needs, in 95% of health facilities; Renforcer la lutte contre les maladies et la promotion de la santé à travers les attitudes et les pratiques individuelles, familiales et communautaires. // Strengthen disease control and health promotion through individual, family and community attitudes and practices; Assurer la disponibilité et l’utilisation  d’informations sanitaires de qualité  pour la prise de décisions à tous les niveaux. // Ensure the availability and use of quality health information for decision-making at all levels; Réduire le taux de mortalité du paludisme d’au moins 75% par rapport à 2015 au Burkina Faso d’ici à fin 2026. // Reduce the malaria mortality rate in Burkina Faso by at least 75% compared with 2015, by the end of 2026; Réduire l’incidence du paludisme d’au moins 75% par rapport à 2015 au Burkina Faso d’ici à fin 2026. // Reduce the incidence of malaria in Burkina Faso by at least 75% compared with 2015, by the end of 2026; Réduire l’incidence de la tuberculose de 45 en 2021 à 36 cas/100 000 habitants en 2026. // Reduce the incidence of tuberculosis from 45 in 2021 to 36 cases/100,000 inhabitants in 2026; Reduire le taux de mortalité de la tuberculose de 6,4 en 2021 à 1,5 décès/100 000 habitants d’ici à fin 2026. // Reduce the tuberculosis mortality rate from 6.4 in 2021 to 1.5 deaths/100,000 inhabitants by the end of 2026; Accroître le taux de succès au traitement des patients TB pharmaco sensibles de 81,5% (cohorte 2020) à au moins 90% (cohorte 2025) et ceux TB-résistante de 75% (cohorte 2020) à au moins 80% (cohorte 2025). // Increase the treatment success rate for drug-susceptible TB patients from 81.5% (cohort 2020) to at least 90% (cohort 2025), and for drug-resistant TB patients from 75% (cohort 2020) to at least 80% (cohort 2025); Les nouvelles infections à VIH sont réduites de 75% à l’horizon 2026. // New HIV infections reduced by 75% by 2026; La mortalité liée au VIH est réduite de 70% chez les PVVIH y compris chez les co-infectées à l'horizon 2025 // HIV-related mortality reduced by 70% among PLHIV, including co-infected people, by 2025; 95% des personnes infectées et affectées par le VIH ainsi que les OEV du SIDA ont une qualité de vie améliorée en matière de droits, d’égalité du genre de soutien et de protection à l'horizon 2026. // 95% of people infected and affected by HIV and OVC living with AIDS have an improved quality of life in terms of rights, gender equality, support and protection by 2026.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="24" role="2" crs-channel-code="23000">
      <narrative>Faso - Action pour le Développement Communautaire</narrative>
    </participating-org>
    <participating-org type="24" role="4" crs-channel-code="23000">
      <narrative>Faso - Action pour le Développement Communautaire</narrative>
    </participating-org>
    <other-identifier ref="BFA-C-FDCP01" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="2" />
    <activity-date type="1" iso-date="2025-01-01" />
    <activity-date type="2" iso-date="2025-01-01" />
    <activity-date type="3" iso-date="2026-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>xxxx xxxx</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>xxxx</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="BF" percentage="100">
      <narrative>Burkina Faso</narrative>
    </recipient-country>
    <sector vocabulary="1" code="13040" percentage="59.19">
      <narrative>HIV</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="22.49">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <sector vocabulary="1" code="12263" percentage="18.32">
      <narrative>Tuberculosis</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="aecf0171-ec0b-4298-be44-3c2a390d7a69" percentage="1.67">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Community-based testing for KP programs</narrative>
        </description>
      </budget-item>
      <budget-item code="86dc2898-1dfb-4559-a4cb-72cd5a2cd403" percentage="7.71">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; HIV prevention communication, information and demand creation for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="7300b0bf-fc7f-49ac-b933-534346c226a5" percentage="0.3">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programming for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="a120a70d-52df-43de-97e1-765d63db4170" percentage="0.85">
        <description>
          <narrative>HIV -&gt; Prevention package for people in prisons and other closed settings -&gt; HIV prevention communication, information and demand creation for prisoners</narrative>
        </description>
      </budget-item>
      <budget-item code="394d6538-8808-4811-b96b-d6bf71843cb6" percentage="14.88">
        <description>
          <narrative>HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; HIV prevention communication, information and demand creation for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="e6662a80-0f0d-4611-990c-6044696834dc" percentage="1.09">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Community mobilization and advocacy for human rights</narrative>
        </description>
      </budget-item>
      <budget-item code="9bcc0e33-1356-4897-a1b3-d9171e326a60" percentage="6.03">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Eliminating stigma and discrimination in all settings</narrative>
        </description>
      </budget-item>
      <budget-item code="39d71dad-c8af-467d-9fcc-8ac534b86784" percentage="1.14">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Ensuring nondiscriminatory provision of health care</narrative>
        </description>
      </budget-item>
      <budget-item code="10e03ea0-16be-40e1-9fba-682edec921d0" percentage="3.32">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Ensuring rights-based law enforcement practices</narrative>
        </description>
      </budget-item>
      <budget-item code="28c1900d-472f-4af5-94d7-2b92f93ab743" percentage="9.71">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Increasing access to justice (HIV/TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="ecc245de-32bf-41ff-8eb1-f5fae2eb1557" percentage="0.31">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Legal literacy ("Know Your Rights") (HIV/TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="e0bd4666-bd16-440a-81d4-ded76d1d1b10" percentage="3.56">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Reducing HIV-related gender discrimination, harmful gender norms and violence against women and girls in all their diversity</narrative>
        </description>
      </budget-item>
      <budget-item code="d49b353e-9087-48e0-9c3b-f8ed91d6fd53" percentage="8.29">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; HIV treatment and differentiated service delivery - adults (15 and above)</narrative>
        </description>
      </budget-item>
      <budget-item code="6bb2376e-8c74-4cf1-98f0-f72ea58797fa" percentage="0.34">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; HIV treatment and differentiated service delivery - children (under 15)</narrative>
        </description>
      </budget-item>
      <budget-item code="43337786-bfab-487f-b388-9fbe8808948d" percentage="17.5">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="db62704e-5b08-4eb1-b5cb-39a697705c19" percentage="0.71">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Capacity building and leadership development</narrative>
        </description>
      </budget-item>
      <budget-item code="f94cd008-2af3-49cf-9149-7be7cf0228e7" percentage="3.14">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Data quality</narrative>
        </description>
      </budget-item>
      <budget-item code="42e7a4b3-fa75-4c16-8a4d-110492b156f4" percentage="1.14">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="95211519-fdf1-4ae4-964d-27e8afa798cf" percentage="4.59">
        <description>
          <narrative>Tuberculosis -&gt; Collaboration with other providers and sectors -&gt; Community-based TB/DR-TB care</narrative>
        </description>
      </budget-item>
      <budget-item code="ea39b4f6-cd94-4310-b181-394f794f9144" percentage="5.15">
        <description>
          <narrative>Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB diagnosis/drug susceptibility testing (DST)</narrative>
        </description>
      </budget-item>
      <budget-item code="5b20da70-c625-405c-858b-6de52626ae46" percentage="0.4">
        <description>
          <narrative>Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB treatment, care and support</narrative>
        </description>
      </budget-item>
      <budget-item code="9bcbb01c-6f63-414e-a67b-9a54f6bd04c0" percentage="2.29">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Miners and mining communities</narrative>
        </description>
      </budget-item>
      <budget-item code="1ed5e501-534e-43ae-bb9f-9552bd6bf461" percentage="4.69">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Mobile population (migrants/refugees/IDPs)</narrative>
        </description>
      </budget-item>
      <budget-item code="23608000-3108-4c67-92d0-b1a31eb68b3f" percentage="0.85">
        <description>
          <narrative>Tuberculosis -&gt; Removing human rights and gender related barriers to TB services -&gt; Eliminating TB-related stigma and discrimination</narrative>
        </description>
      </budget-item>
      <budget-item code="7c7a7505-bdfe-4146-976c-78a03ca0d545" percentage="0.13">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Screening, testing and diagnosis</narrative>
        </description>
      </budget-item>
      <budget-item code="c03db068-1593-4995-bf69-fe67549bd239" percentage="0.21">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Treatment and care</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2025-01-01" />
      <period-end iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-01-01">3492960.02</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2026-01-01" />
      <period-end iso-date="2026-12-31" />
      <value currency="USD" value-date="2026-01-01">3371264.57</value>
    </budget>
    <capital-spend percentage="2.14" />
    <transaction ref="7d2643c1-899d-42c1-9003-611bbf26ee6c">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-03-11" />
      <value currency="USD" value-date="2025-03-11">3289939.97</value>
      <description>
        <narrative>Global Fund commitment to BFA-C-FDCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Faso - Action pour le Développement Communautaire</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3a2edbb7-9661-451d-8045-e2058810de6c">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-03-13" />
      <value currency="USD" value-date="2025-03-13">1310014.73</value>
      <description>
        <narrative>Global Fund disbursement to BFA-C-FDCP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Faso - Action pour le Développement Communautaire</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5989e74d-40ef-40f5-acb5-d26d15d70754">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-05-27" />
      <value currency="USD" value-date="2025-05-27">7369.60</value>
      <description>
        <narrative>Global Fund disbursement to BFA-C-FDCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Faso - Action pour le Développement Communautaire</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="abd942ff-67b2-4890-b706-bc3a3f782ab6">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-08-05" />
      <value currency="USD" value-date="2025-08-05">6634.37</value>
      <description>
        <narrative>Global Fund disbursement to BFA-C-FDCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Faso - Action pour le Développement Communautaire</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="187107e4-e66b-4cb3-b457-23222a5dc15b">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-11-25" />
      <value currency="USD" value-date="2025-11-25">1743994.17</value>
      <description>
        <narrative>Global Fund disbursement to BFA-C-FDCP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Faso - Action pour le Développement Communautaire</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="138d8f02-b954-443b-ba17-20d4351ea627">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-11-25" />
      <value currency="USD" value-date="2025-11-25">7436.19</value>
      <description>
        <narrative>Global Fund disbursement to BFA-C-FDCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Faso - Action pour le Développement Communautaire</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="47f00ee7-0d8a-439e-825a-c7e75f28bfc6">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-03-10" />
      <value currency="USD" value-date="2026-03-10">7334.92</value>
      <description>
        <narrative>Global Fund disbursement to BFA-C-FDCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Faso - Action pour le Développement Communautaire</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d185e5fd-ce58-4a04-b27e-4c2952b08b5e">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-07-27" />
      <value currency="USD" value-date="2026-07-27">3393809.52</value>
      <description>
        <narrative>Global Fund commitment to BFA-C-FDCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Faso - Action pour le Développement Communautaire</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d6850560-3c06-429a-a4b9-45861f94e9c1">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-07-27" />
      <value currency="USD" value-date="2026-07-27">-207155.99</value>
      <description>
        <narrative>Global Fund commitment to BFA-C-FDCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Faso - Action pour le Développement Communautaire</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8ed01ef8-f6a2-4ec4-8264-1ffd3141f58e">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-08-04" />
      <value currency="USD" value-date="2026-08-04">1053958.27</value>
      <description>
        <narrative>Global Fund disbursement to BFA-C-FDCP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Faso - Action pour le Développement Communautaire</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="309276c4-9aa8-4314-9c52-66daecedfb89">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-08-04" />
      <value currency="USD" value-date="2026-08-04">7907.62</value>
      <description>
        <narrative>Global Fund disbursement to BFA-C-FDCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Faso - Action pour le Développement Communautaire</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="562f8924-cfc5-44e1-8c58-2e5a9a787888">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-08-04" />
      <value currency="USD" value-date="2026-08-04">14657.68</value>
      <description>
        <narrative>Global Fund disbursement to BFA-C-FDCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Faso - Action pour le Développement Communautaire</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4c462ee6-981f-4693-b34b-a72dc4d2898e">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-10-20" />
      <value currency="USD" value-date="2026-10-20">2296114.74</value>
      <description>
        <narrative>Global Fund disbursement to BFA-C-FDCP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Faso - Action pour le Développement Communautaire</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="60996f6a-8a24-4a51-9794-dde69ca07811">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-10-20" />
      <value currency="USD" value-date="2026-10-20">7057.07</value>
      <description>
        <narrative>Global Fund disbursement to BFA-C-FDCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Faso - Action pour le Développement Communautaire</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="BFA-C-FDCP01-EXP-20251231">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-12-31">689199.60</value>
      <description>
        <narrative>Expenditure reported by Faso - Action pour le Développement Communautaire for BFA-C-FDCP01, Jan 2025 to Dec 2025.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Faso - Action pour le Développement Communautaire</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/BFA-C-FDC" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-07" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>HTS 3 - Other 1 Percentage of PHR who were tested for HIV during the reporting period in programmes specifically aimed at key populations and who know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>HTS 3 - Other 1 Percentage of PHR who were tested for HIV during the reporting period in programmes specifically aimed at key populations and who know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="26.15">
          <comment>
            <narrative>Numerator: 4546; Denominator: 17381.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="49.4">
            <comment>
              <narrative>Numerator: 9062.7; Denominator: 18354.</narrative>
            </comment>
          </target>
          <actual value="14.1">
            <comment>
              <narrative>Numerator: 2587; Denominator: 18354.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="49.38">
            <comment>
              <narrative>Numerator: 9062.73; Denominator: 18354.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="49.38">
            <comment>
              <narrative>Numerator: 9062.73; Denominator: 18354.</narrative>
            </comment>
          </target>
          <actual value="14.1">
            <comment>
              <narrative>Numerator: 2587; Denominator: 18354.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="54.2">
            <comment>
              <narrative>Numerator: 10221.84; Denominator: 18860.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="54.2">
            <comment>
              <narrative>Numerator: 10221.84; Denominator: 18860.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of sex workers that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of sex workers that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31">
          <comment>
            <narrative>Numerator: 30674; Denominator: 52003; Percentage: 58.99%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 15037; Denominator: 52003; Percentage: 28.92%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 30674; Denominator: 52003; Percentage: 58.99%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 31626.9; Denominator: 54913; Percentage: 57.6%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 14323; Denominator: 54913; Percentage: 26.08%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 31626.9; Denominator: 54913; Percentage: 57.59%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 31626.9; Denominator: 54913; Percentage: 57.59%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 14323; Denominator: 54913; Percentage: 26.08%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 7375.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 14323.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 31646.7; Denominator: 56429; Percentage: 56.08%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 31646.7; Denominator: 56429; Percentage: 56.08%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>KP 1 - Other 1 Percentage of PHR having had access to HIV prevention programmes - defined service package</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for men who have sex with men (MSM) and their sexual partners.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>KP 1 - Other 1 Percentage of PHR having had access to HIV prevention programmes - defined service package</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="27.95">
          <comment>
            <narrative>Numerator: 4858; Denominator: 17381.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="54.9">
            <comment>
              <narrative>Numerator: 10069.7; Denominator: 18354.</narrative>
            </comment>
          </target>
          <actual value="41.4">
            <comment>
              <narrative>Numerator: 7599; Denominator: 18354.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="54.86">
            <comment>
              <narrative>Numerator: 10069.7; Denominator: 18354.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="54.86">
            <comment>
              <narrative>Numerator: 10069.7; Denominator: 18354.</narrative>
            </comment>
          </target>
          <actual value="41.4">
            <comment>
              <narrative>Numerator: 7599; Denominator: 18354.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="60.22">
            <comment>
              <narrative>Numerator: 11357.6; Denominator: 18860.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="60.22">
            <comment>
              <narrative>Numerator: 11357.6; Denominator: 18860.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>KP 6 - Other 1 Number of PHR who received a PrEP product at least once during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for men who have sex with men (MSM) and their sexual partners.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>KP 6 - Other 1 Number of PHR who received a PrEP product at least once during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31">
          <comment>
            <narrative>Numerator: 294; Denominator: 2129; Percentage: 13.81%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 196.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 665.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 98.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 98.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 626.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 114.5.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 114.5.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of sex workers who received any PrEP product at least once during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for sex workers, their clients and other sexual partners.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of sex workers who received any PrEP product at least once during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31">
          <comment>
            <narrative>Numerator: 1067; Denominator: 3199; Percentage: 33.35%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1067; Denominator: 3199; Percentage: 33.35%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="PrEP product" value="Oral PrEP" />
          <comment>
            <narrative>Numerator: 1067; Denominator: 3199; Percentage: 33.35%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 174.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 348.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2421.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 174.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2365.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 2365.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="PrEP product" value="Oral PrEP" />
            <comment>
              <narrative>Numerator: 2365.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 174.5.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 174.5.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of sex workers reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for sex workers, their clients and other sexual partners.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of sex workers reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31">
          <comment>
            <narrative>Numerator: 29632; Denominator: 52003; Percentage: 56.98%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 14655; Denominator: 52003; Percentage: 28.18%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 29632; Denominator: 52003; Percentage: 56.98%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 35141; Denominator: 54913; Percentage: 63.99%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 35141; Denominator: 54913; Percentage: 64%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 46126; Denominator: 54913; Percentage: 84%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 35141; Denominator: 54913; Percentage: 63.99%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 46126; Denominator: 54913; Percentage: 84%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 21225.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 46126.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 35163; Denominator: 56429; Percentage: 62.31%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 35163; Denominator: 56429; Percentage: 62.31%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of service delivery reports from community health units integrated/interoperable with the national HMIS</narrative>
      </title>
      <description>
        <narrative>Module: RSSH: Monitoring and evaluation systems.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of service delivery reports from community health units integrated/interoperable with the national HMIS</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="100">
          <comment>
            <narrative>Numerator: 1776; Denominator: 1776.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 612; Denominator: 612.</narrative>
            </comment>
          </target>
          <actual value="88.63">
            <comment>
              <narrative>Numerator: 460; Denominator: 519.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 306; Denominator: 306.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 306; Denominator: 306.</narrative>
            </comment>
          </target>
          <actual value="207.27">
            <comment>
              <narrative>Numerator: 342; Denominator: 165.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 306; Denominator: 306.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 306; Denominator: 306.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- community referrals; *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- community referrals; *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="31.49">
          <comment>
            <narrative>Numerator: 2305; Denominator: 7320.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="40">
            <comment>
              <narrative>Numerator: 1681; Denominator: 4202.5.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="40">
            <comment>
              <narrative>Numerator: 3362; Denominator: 8405.</narrative>
            </comment>
          </target>
          <actual value="11.39">
            <comment>
              <narrative>Numerator: 1174; Denominator: 10308.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="40">
            <comment>
              <narrative>Numerator: 1681; Denominator: 4202.5.</narrative>
            </comment>
          </target>
          <actual value="15.81">
            <comment>
              <narrative>Numerator: 821; Denominator: 5194.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="40">
            <comment>
              <narrative>Numerator: 1752.6; Denominator: 4381.5.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="40">
            <comment>
              <narrative>Numerator: 1752.6; Denominator: 4381.5.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
  </iati-activity>
</iati-activities>